ALK Positive
@alkpositiveinc
We are a patient-driven organization, dedicated to improving the life expectancy & quality of life for ALK-positive cancer patients worldwide. #StrongerTogether
ID: 992571347447492608
http://www.alkpositive.org 05-05-2018 01:07:05
2,2K Tweet
2,2K Followers
918 Following
Treatment landscape for EGFR #lungcancer is getting more complex - for clinicians & patients. But as Dr Jurgen Wolf says at #ESMO24 “Always good to have several arrows in your quiver.” Absolutely agree. Stratifying which patients are best for which option is key Jurgen Wolf
🌟And here with the efficacy and safety data of #NVL655, ALK-selective, TRK-sparing and brain-penetrant 4G ALK TKI, from ALKOVE-1, presented today #ESMO24 by Alexander Drilon MD ✅ ORR 38% in heavily pretreated pts overall (1-5 prior ALK TKIs) ✅ ORR 35% in pts post-lorlatinib (in which
After adjuvant Alectinib for early stage ALK lung cancer, how to you handle progression? Can you re-challenge with Alectinib? Dr Ben Solomon answers these questions at #ESMO24 👇
Starting soon for those interested in learning more about local therapies for ALK+ stage IV NSCLC. ALK Positive Yvonne Diaz Oncogene Cancer Research alkpositivebelgium ALK+ International ALK Positive Australia Inc. @
Important data. Next step is to translate this into practice and policy. Unfortunately, surveillance brain MRI are still NOT routinely recommended in most society guidelines for early stage NSCLC, especially for #EGFR & #ALK. #LCSM Chat EGFR Resisters ALK Positive
Great to be joining Drs Christian Rolfo Marina Garassino & Sanjay Popat at LUNGevity Foundation's International Lung Cancer Survivorship Conference taking place this weekend. Incredible agenda featuring many key opinion leaders & patient advocates. Join 👇reg.eventmobi.com/ilcsc24/regist… #ILCSC
Dr. Ken Culver, our Research & Clinical Affairs Director, spoke with Lung Cancers Today Today at #WCLC24 about how we're supporting research through our patient registry - the ALK Life Study. Ken also spoke about the importance of #biomarkertesting for all lung cancers. 📺👇 #LCSM
Celebrating 20 yrs of progress in lung cancer is truly down to research bringing us improvements in treatments &s quality of life. Thanks Prof Solange Peters CHUV / Centre hospitalier universitaire vaudois for highlighting lots of research, including 23andMe Lung Cancer Genetics Study. 23andme.com/lung-cancer/?u…
Watch the replay of our recent ALKtALK w Drs Drew Moghanaki 🐕 & Matt Quirk - looking at the use of all forms of radiotherapy when tumors won't disappear. Lots of great topics covered the roles of ablation, radiotherapy & LCT for our ALK #lungcancer family. 📺youtu.be/5IhdEqbubzY?si…
Great line up today @lungevity’s #ILCSC w many dedicated patient advocates & clinicians. Truly international & representative conf. Still time to register @ lungevity.org/ilcsc Our Co-founder Yvonne Diaz on at 9amET w Sanjay Popat Dr Marina Garassino & Christian Rolfo